Hungarian Pancreatic Study Group – Magyar Hasnyálmirigy Munkacsoport 4 th Conference of the Hungarian & 2 nd Conference of the Eastern and Central European.

Slides:

Advertisements

Similar presentations

Metadata-based analysis to improve clinical trial exchange Daniela Luzi*, Fabrizio L. Ricci *, Luca Dan Serbanati# *National Research Council - Institute.

Advertisements

AUTHORSHIP SKILLS: QUESTIONS SCIENTISTS FREQUENTLY ASK ABOUT THE WRITING AND PUBLISHING OF JOURNAL ARTICLES.

Susan Burner Bankowski, M.S., J.D. Chair, OHSU IRB

Presented by, Aarti Vaishnav, MS CRIC Director. We are a team of 13 full time programmers and about 10 part time students.

Mary Barton, MD, MPP Vice President, Performance Measures “Balancing scientific and social dimensions of guidelines”

The regulation of research by funding bodies: an emerging ethical issue for the alcohol and other drug sector? Peter Miller 1, David Moore 2 and John Strang.

Open access innovations in clinical research reporting October 22 nd 2012 Iain Hrynaszkiewicz Publisher (Open Science), BioMed Central

CADGME 2009 Conference and IJTME Carrie Headlam Centre for Teaching Mathematics University of Plymouth.

The Pursuit of Better Medicines through Genetic Research Terri Arledge, DVM US Department Head Drug Development Genetics.

Research & Innovation International Rare Disease Consortium: Data Sharing Policy 3 rd International Traumatic Brain Injury Research Meeting Catherine BERENS.

U SAGE S TATISTICS FOR S PRINGER P RODUCTS T RIAL IN H UNGARY, F EBRUARY – M ARCH 2013 Tiberius Ignat and Peter Szanto Scientific Knowledge Services.

Helping the people of Canada maintain and improve their health Aider les Canadiens et les Canadiennes à maintenir et à améliorer leur santé Health Canada’s.

Special Issues in FDA-Regulated Studies: The Good, the Bad, and the Ugly C. Karen Jeans, MSN, CCRN, CIP COACH Program Analyst VA Office of Research & Development.

Tidsskriftet Fysioterapeuten Norwegian Journal of Physiotherapy John H. Strupstad, Scientific Editor.

Objectives of Work Package 5 objectives for today Information on centres of expertise for rare cancers WP leader: Sabine Siesling.

Registering and analyzing malaria clinical trials in Africa: the PACT registry initiative Vittoria Lutje*^, Annette Gerritsen**, Nandi Siegfried***. Paul.

Zsolt Kajcsos Photo courtesy of Prof. Reinhard Krause-Rehberg.

Improving Access and Quality Use of Medicines in Palliative Care within National Drug Policy, Regulatory, and Funding Frameworks Debra Rowett, Tania Shelby-James,

The QA/QI Process Human Research Subjects Protection Human Investigation Committee Tracy Rightmer, JD, CIP Compliance Manager.

LIGO-G R LSC Presentations Policy: a proposal for procedures David Shoemaker and Peter Saulson LSC, Livingston 14 March 2001.

Gynecologic Oncology Group Gynecologic Oncology Group (GOG) Sharon Stockman, C-CRC The University of Iowa Hospitals Iowa City, IA Chair, GOG Data Management.

Cancer Centers In Clinical Trials Sandrine Marreaud Head of Medical Department.

Next step in Iranian Clinical Trial Registration movement Masoud Solaymani-Dodaran MD MPH PhD CCT FFPH.

Engaging with best editorial and publication practice Shreeya Nanda Deputy Editor.

ClinicalTrials.gov Results Reporting, Unique Evidence, and the Role of Medical Librarians SCR CONNECTions March 19, 2014.

HA Research Ethics Development HA REC Meeting 6/2/2004 HA REC Meeting 6/2/2004.

Scientific Opportunities and Public Needs Resource Allocation and Priority Setting at the NIH.

Hungarian Pancreatic Study Group – Magyar Hasnyálmirigy Munkacsoport Gábor Lakatos 09 november th Conference of the Hungarian & 2 nd Conference.

Hungarian Pancreatic Study Group – Magyar Hasnyálmirigy Munkacsoport 4 th Conference of the Hungarian & 2 nd Conference of the Eastern and Central European.

Hungarian Pancreatic Study Group – Magyar Hasnyálmirigy Munkacsoport on behalf of the Hungarian Pancreatic Study Group 4 th Conference of the Hungarian.

Trusted evidence. Informed decisions. Better health. Cochrane_QuickRefBooklet.indd 114/8/15 5:41 pm.

Hungarian Pancreatic Study Group – Magyar Hasnyálmirigy Munkacsoport Dóra Mosztbacher on behalf of the Hungarian Pancreatic Study Group SZEKSZÁRD, HUNGARY.

Guidelines for Clinical Trial Registration.. Background. In 2005 the International Committee of Medical Journal Editors (ICMJE) announced that in order.

Hungarian Pancreatic Study Group – Magyar Hasnyálmirigy Munkacsoport Andrea Szentesi on behalf of the Hungarian Pancreatic Study Group SZEGED, HUNGARY.

Alun JONES EU Network Manager European Agency for Safety and Health at Work 6 th Framework Programme on Research.

Ethical Issues in the Publication of Clinical Trial Information The International Pharmaceutical Compliance Summit on Medical Affairs, Clinical Trials,

Hungarian Pancreatic Study Group – Magyar Hasnyálmirigy Munkacsoport 4 th Conference of the Hungarian & 2 nd Conference of the Eastern and Central European.

An initiative of the International Rare Diseases Research Consortium-IRDiRC Spanish Rare Diseases Registries Research Network - SpainRDR

Hungarian Pancreatic Study Group – Magyar Hasnyálmirigy Munkacsoport Andrea Szentesi on behalf of the Hungarian Pancreatic Study Group SZEGED, HUNGARY.

HA Central Register of Clinical Research 1 Dec 04 HA REC.

Chronic Disease Tracking System  Problem  The current healthcare model focuses on one patient at a time in the office.  Chronic disease leads to higher.

NSW Government Agencies Supporting Clinical Trials Strategic Planning, Policy Advice & Funding for Medical Research Economic Development & Support for.

1 AVAREF MEETING – 24 th, September, 2010 Nairobi - Kenya Registry component: Pilot Implementation Experience in Tanzania Fimbo,

R1. 이용석 / modulator pf. 동석호. Introduction Acute pancreatitis(AP) ▫most common disease that affects the pancreas ▫incidence of AP varies globally, affecting.

A capacity building programme for patient representatives

Recording and Reporting Clinical Trial Results

pSS: primary SS; Scl: scleroderma.

Figure 1 Study flow chart.

Quantitative Renal Echogenicity as a Tool for Diagnosis of Advanced Chronic Kidney Disease in Patients with Glomerulopathies and no Liver Disease Kidney.

New Issue Released by Journal of Gastroenterology - Volume 4 - Issue 6 – 2017

How to write a project plan Ove Karlsson

Pancreatic Cancer (C25):

AUTHORSHIP SKILLS: QUESTIONS SCIENTISTS FREQUENTLY ASK ABOUT THE WRITING AND PUBLISHING OF JOURNAL ARTICLES This work is licensed under a Creative Commons.

International prospective observational StudY on iNtrAcranial PreSsurE in intensive care (ICU) The SYNAPSE-ICU Study ClinicalTrials.gov Identifier: NCT

PAHO/WHO Research Policies and Strategies

Progression After Cancer Immunotherapy in Advanced NSCLC

Physician / Patient Future Collaboration Opportunities

Factors That Affect Risk for Pancreatic Disease in the General Population: A Systematic Review and Meta-analysis of Prospective Cohort Studies Ammar.

Ethics: The practical nuts and bolts

AACR Project GENIE at a glance.

Consent and eligibility for Clinical Trials: Learning Burst 4

AUTHORSHIP SKILLS: QUESTIONS SCIENTISTS FREQUENTLY ASK ABOUT THE WRITING AND PUBLISHING OF JOURNAL ARTICLES.

Design of the trial. Design of the trial. (1) Patients with advanced recurrent pancreatic cancer aged ≥75 years, (2) unresectable/recurrence, (3) -performance.

Scientific Panel Study Approval Process

Speaking on Behalf of ASME

Target disease and target populations for 21st century vaccine developmentIncluded in the list are the agents of infectious diseases for which vaccines.

Drug Information Resources

Distribution of patients in the first- or second-year follow-up according to the number of acute exacerbations of chronic obstructive pulmonary disease.

Publications & Ancillary Studies

Figure 1. Forest plot of lung cancer mortality in LDCT trials.

Presentation transcript:

Hungarian Pancreatic Study Group – Magyar Hasnyálmirigy Munkacsoport 4 th Conference of the Hungarian & 2 nd Conference of the Eastern and Central European Pancreatic Study Groups PROSPECTIVE CLINICAL TRIALS Péter Hegyi on behalf of the Hungarian Pancreatic Study Group Chair of HPSG SZEGED, HUNGARY

Hungarian Pancreatic Study Group – Magyar Hasnyálmirigy Munkacsoport 4 th Conference of the Hungarian & 2 nd Conference of the Eastern and Central European Pancreatic Study Groups PROSPECTIVE CLINICAL TRIALS GENERAL REGISTRY HORIZONTAL STUDIES ACUTE PANCREATITIS CHRONIC PANCREATITIS PANCREATIC CANCER AUTOIMMUNE PANCRETITIS EASY PREPAST APPLE PNEAPPLE

Hungarian Pancreatic Study Group – Magyar Hasnyálmirigy Munkacsoport 4 th Conference of the Hungarian & 2 nd Conference of the Eastern and Central European Pancreatic Study Groups PROSPECTIVE CLINICAL TRIALS 1.The protocols have to be discussed in one of the international meetings 2.The studies have to receive the relevant ethical approvals issued by the National Hungarian Ethical Authority (In Hungary: ETT TUKEB). 3.The trials have to be registered at the ISRCTN registry is a primary clinical trial registry recognized by WHO and ICMJE. 4.Authorhip policy should be provided in advance 5.The studies have to be open for all centers throughout the world. 5. Electronic CRF has to be developed. 6.The study should be sent to the IAP Scientific Committee 7.The TRIAL article (prestudy protocol) has to be published

Hungarian Pancreatic Study Group – Magyar Hasnyálmirigy Munkacsoport 4 th Conference of the Hungarian & 2 nd Conference of the Eastern and Central European Pancreatic Study Groups PROSPECTIVE CLINICAL TRIALS

Hungarian Pancreatic Study Group – Magyar Hasnyálmirigy Munkacsoport 4 th Conference of the Hungarian & 2 nd Conference of the Eastern and Central European Pancreatic Study Groups PROSPECTIVE CLINICAL TRIALS EASY PREPAST ZSOLT DUBRAVCSIK ISTVÁN HRITZ APPLE ANDREA PÁRNICZKY PINEAPPLE DÓRA MOSZTBACHER

Hungarian Pancreatic Study Group – Magyar Hasnyálmirigy Munkacsoport 4 th Conference of the Hungarian & 2 nd Conference of the Eastern and Central European Pancreatic Study Groups PROSPECTIVE CLINICAL TRIALS Prospective trials

Hungarian Pancreatic Study Group – Magyar Hasnyálmirigy Munkacsoport 4 th Conference of the Hungarian & 2 nd Conference of the Eastern and Central European Pancreatic Study Groups PROSPECTIVE CLINICAL TRIALS

Hungarian Pancreatic Study Group – Magyar Hasnyálmirigy Munkacsoport 4 th Conference of the Hungarian & 2 nd Conference of the Eastern and Central European Pancreatic Study Groups PROSPECTIVE CLINICAL TRIALS PI PA 1.ethical approval 2.registation at ISRCTN 3.electronic CRF 4.IAP Scientific Committee

THE HUNGARIAN PANCREATIC STUDY GROUP IS COMMITTED TO IMPROVING THE LIFES OF PATIENTS SUFFERING FROM PANCREATIC DISEASES! Hungarian Pancreatic Study Group – Magyar Hasnyálmirigy Munkacsoport 4 th Conference of the Hungarian & 2 nd Conference of the Eastern and Central European Pancreatic Study Groups HUNGARIAN COHORT - PANCREATIC CANCER (PC)